Round robin trial


NordiQC Run B29 2020 „PR“

PR, Clone SP42 (RBK020) – Assessment Results

Download

NordiQC Run B28 2019 „HER2 IHC“

HER2, Clone EP3 (RBK067) – Assessment Results

Download

NordiQC Run 58 2020 „TTF1“

TTF1, Clone SPT24 (MSK111) – Assessment Results

Download

NordiQC Run 58 2020 „NKX3.1“

NKX3.1, Polyklonal (RBK062) – Assessment Results

Download

NordiQC Run 58 2020 „MUM1“

MUM1, Clone SP114 (513-4140) – Assessment Results

Download

NordiQC Run 57 2019 „MSH2“

MSH2, Clone FE11 (MSG031) – Assessment Results

Download

NordiQC Run 55 2019 „CK5“

Cytokeratin 5 & 14, Clone XM26 + LL002 (MSK106) – Assessment Results.

Download

NordiQC Run 55 2019 „ER“

Estrogen Receptor, Clone SP1 (RBK018) – Assessment Results.

Download

NordiQC Run 56 2019 „Melan A (MLA)“

MART-1 (Melan-A), Clone M2-7C10 (MSK056) – Assessment Results.

Download

NordiQC Run C5 2019 „PD-L1 (uro)“

Focused on the accuracy of PD-L1 IHC assays in order to identify patients with urothelial carcinomas to be treated with Pembrolizumab as immune therapy, PD-L1, Clone CAL10 (RBK063) – Assessment Results.

Download

NordiQC Run C5 2019 „PD-L1 (lung)“

Focused on the accuracy of PD-L1 IHC assays in order to identify patients with non-small cell lung carcinoma (NSCLC) benefitting from immune therapy with Pembrolizumab, PD-L1, Clone CAL10 (RBK063) – Assessment Results.

 

Download


back to Certificates